[1]梁碧颜,吴煜,雒琳,等.中医药防治大肠癌术后复发转移前瞻性队列研究[J].中国中医药信息杂志,2008,15(11):12-14.
 LIANG Bi-yan,WU Yu,LUO Lin,et al.Prospective Cohort Study on TCM to Protecting Relapse and Metastasis of Postoperative Colorectal Cancer[J].zhongguo zhongyiyao xinxi zazhi,2008,15(11):12-14.
点击复制

中医药防治大肠癌术后复发转移前瞻性队列研究

参考文献/References:

[1] D Max Parkin, Freddie Bray, J Ferlay, et al. Global Cancer Statistics,2002[J]. CA Cancer J Clin,2005,55:74-108.

[2] 全国肿瘤防治办公室.中国试点市、县恶性肿瘤的发病与死亡(第2卷)[M].北京:中国医药科技出版社,2002.24.

[3] Jeffrey A, Meyerhard T, Robert J Mayer. Systemic therapy for colorectal cancer[J]. N Engl Med,2005,352:476-487.

[4] 汤钊猷,朱世能,曹世龙.现代肿瘤学[M].上海:上海医科大学出版社, 1993.266-274,546.

[5] 孙 燕,周际昌.临床肿瘤内科手册[M].第4版.北京:人民卫生出版社, 2003.337-339.

[6] Nicum S. Chemotherapy for colorectal cancer[J]. J R Soc Med, 2000,93:416-419.

相似文献/References:

[1]梁碧颜,吴煜,吴佳,等.大肠癌临终患者舌象特征[J].中国中医药信息杂志,2010,17(5):19.
 LIAO Ming-juan,KUI Gang,WANG Yong-ling,et al.Analysis of Randomized Controlled Trials of Traditional Chinese Medicine for Recurrent Oral Ulcer[J].zhongguo zhongyiyao xinxi zazhi,2010,17(11):19.
[2]曾柏荣,刘华,李阳.抗癌防移片在大肠癌术后治疗中的作用[J].中国中医药信息杂志,2009,16(3):61.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(11):61.
[3]舒涛,邱剑锋,袁亮,等.李国栋运用中药干预大肠癌术后经验介绍[J].中国中医药信息杂志,2009,16(4):80.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(11):80.
[4]刘静,朱琦.健脾中药联合化疗改善大肠癌患者免疫功能的系统评价[J].中国中医药信息杂志,2009,16(12):104.
 LIU Jing,ZHU Qi.The Improvement of Immunity in Colorectal Caner Patients Receiving Jianpi Herbs Combine Chemotherapy:A Systematic Review[J].zhongguo zhongyiyao xinxi zazhi,2009,16(11):104.
[5]李秀荣,齐元富,周延峰.平移合剂抗肿瘤术后转移的临床研究[J].中国中医药信息杂志,2008,15(10):9.
 LI Xiu-rong,QI Yuan-fu,ZHOU Yan-feng.Clinical Study of Pingyi Mixture on Resisting Tumour Transfer after Surgery[J].zhongguo zhongyiyao xinxi zazhi,2008,15(11):9.
[6]富琦,史琳,杨国旺,等.乳腺癌术后高危人群复发转移影响因素及中医治疗评价[J].中国中医药信息杂志,2014,21(2):27.[doi:10.3969/j.issn.1005-5304.2014.02.008]
 FU Qi,SHI Lin,YANG Guo-wang,et al.Influencing Factors of Recurrence and Metastasis for Postoperative Breast Cancer High-risk Population and Evaluation on TCM Therapy[J].zhongguo zhongyiyao xinxi zazhi,2014,21(11):27.[doi:10.3969/j.issn.1005-5304.2014.02.008]
[7]佘茁萃,姜毅,刘涛,等.肠艾舒对小鼠CT-26大肠癌组织Ki67和PCNA表达的影响[J].中国中医药信息杂志,2014,21(4):52.[doi:10.3969/j.issn.1005-5304.2014.04.017]
 SHE Zhuo-cui,JIANG Yi,LIU Tao,et al.Effect of Chang’aishu on Expression of Ki67 and PCNA in Mice Model with CT-26 Colorectal Cancer[J].zhongguo zhongyiyao xinxi zazhi,2014,21(11):52.[doi:10.3969/j.issn.1005-5304.2014.04.017]
[8]钱垠,黄欣,刘青.健脾中药对结直肠癌术后复发转移的干预作用[J].中国中医药信息杂志,2009,16(1):80.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(11):80.
[9]赵文硕,张青,王笑民.大肠癌的中医诊疗现状[J].中国中医药信息杂志,2008,15(11):103.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(11):103.
[10]唐晓玲,唐 敏,指导:陈 荣.中医药对大肠癌患者免疫功能影响的研究进展[J].中国中医药信息杂志,2005,12(11):104.

备注/Memo

基金项目:首都医学发展科研基金,北京医学卫生科技自主创新和普及推广项目(03-Ⅲ-20)

更新日期/Last Update: